For patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, oral tildacerfont for up to 12 weeks helped to normalize adrenocorticotropic hormone and androstenedione levels in two phase II studies. (Journal of Clinical Endocrinology & Metabolism)
|